These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14534343)

  • 1. High-dose chemotherapy for breast cancer.
    Wheatley K; Gray RG; Ives NJ
    N Engl J Med; 2003 Oct; 349(15):1476-9; author reply 1476-9. PubMed ID: 14534343
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy for breast cancer.
    Dazzi C; Cariello A
    N Engl J Med; 2003 Oct; 349(15):1476-9; author reply 1476-9. PubMed ID: 14535260
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-operative therapy of breast cancer: rationale for adjuvant chemotherapy.
    Butler WM
    J S C Med Assoc; 1984 Jan; 80(1):15-6. PubMed ID: 6371378
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose chemotherapy for breast cancer.
    Tartarone A; Iodice G; Di Renzo N
    N Engl J Med; 2003 Oct; 349(15):1476-9; author reply 1476-9. PubMed ID: 14535261
    [No Abstract]   [Full Text] [Related]  

  • 6. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple gene signatures aim to qualify risk in breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2005 Mar; 97(5):332. PubMed ID: 15741566
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of a gene expression profile on breast cancer decisions.
    Henry LR; Stojadinovic A; Swain SM; Prindiville S; Cordes R; Soballe PW
    J Surg Oncol; 2009 May; 99(6):319-23. PubMed ID: 19204954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy for breast cancer.
    Mangano MM
    N Engl J Med; 2003 Oct; 349(15):1476-9; author reply 1476-9. PubMed ID: 14535262
    [No Abstract]   [Full Text] [Related]  

  • 10. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T; Levine M
    J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
    [No Abstract]   [Full Text] [Related]  

  • 11. End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma RS
    J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
    [No Abstract]   [Full Text] [Related]  

  • 12. [High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].
    Nielsen DL; Svane IM
    Ugeskr Laeger; 2004 Nov; 166(46):4145-7. PubMed ID: 15565848
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonhormonal systemic therapy for advanced breast cancer: do the math!
    Bedard PL; Piccart-Gebhart MJ
    J Natl Cancer Inst; 2008 Dec; 100(24):1745-7. PubMed ID: 19066269
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dosage chemotherapy in breast cancer].
    Sola C; Ojeda B; Brunet J; López López JJ
    Med Clin (Barc); 1997 Mar; 108(10):398-9. PubMed ID: 9139151
    [No Abstract]   [Full Text] [Related]  

  • 15. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].
    Nielsen DL; Svane IM
    Ugeskr Laeger; 2004 Nov; 166(46):4148-50. PubMed ID: 15565849
    [No Abstract]   [Full Text] [Related]  

  • 17. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose chemotherapy in carcinoma of the breast. Sunshine and shadows].
    Lelli G
    Recenti Prog Med; 2000 Dec; 91(12):647-9. PubMed ID: 11194485
    [No Abstract]   [Full Text] [Related]  

  • 19. [High dose chemotherapy and stem cell transplant in patients with operable breast cancer and a poor prognosis; not indicated for the time being].
    Slee PH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(1):9-12. PubMed ID: 14750448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial and error: prognostic gene signature study design altered.
    Tuma RS
    J Natl Cancer Inst; 2005 Mar; 97(5):331-3. PubMed ID: 15741565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.